Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CRISPR Therapeutics AG - Common Shares
(NQ:
CRSP
)
52.22
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CRISPR Therapeutics AG - Common Shares
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
31
32
Next >
CRISPR Therapeutics sets sights on gene-editing cures for disease
December 27, 2023
On Dec. 8, 2023, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) announced the U.S. FDA approved its sickle-cell disease (SCD) treatment, Casgevy, for
Via
MarketBeat
Exposures
Product Safety
3 Top Stocks to Buy Hand Over Fist Before the End of 2023
December 25, 2023
These are ideal stocks to buy sooner rather than later.
Via
The Motley Fool
3 Healthcare Technology Stocks to Improve Lives in 2024
December 25, 2023
Healthcare technology is one of 2024's top investment trends, and investors looking for long-term upside should check out these top stocks.
Via
InvestorPlace
1 Green Flag and 1 Red Flag for Bluebird Bio Stock
December 23, 2023
The stock has been in the news lately.
Via
The Motley Fool
Could CRISPR Therapeutics Stock Help You Become a Millionaire?
December 22, 2023
There are plenty of reasons to be optimistic about CRISPR's future.
Via
The Motley Fool
Where Will CRISPR Therapeutics Be in 5 Years?
December 15, 2023
Does the recent approval make the stock a no-brainer buy?
Via
The Motley Fool
After This Landmark Win, Is CRISPR Therapeutics a Buy?
December 15, 2023
CRISPR Therapeutics stock already has advanced in the double digits this year.
Via
The Motley Fool
Cathie Wood Predicts Deflation In 2024, More AI And Tech Optimism — And Rate Cuts
December 22, 2023
Cathie Wood believes deflation in 2024, aggressive rate cuts and technological progress will drive expansion.
Via
Benzinga
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
3 Money-Saving Tricks for Investing in Biotech Stocks in 2024
December 22, 2023
Doing a little math and doing a little extra research can make a big difference.
Via
The Motley Fool
I'm Begging You to Buy Stocks Before January -- Here's Why
December 22, 2023
Some studies have shown a pattern of market gains in the month of January.
Via
The Motley Fool
Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock?
December 22, 2023
The FDA's recent approval of CRISPR Therapeutics' first therapy is a step in the right direction.
Via
The Motley Fool
Exposures
Product Safety
6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its Gene-Editing Therapy
December 21, 2023
Should you buy CRISPR's stock on the dip?
Via
The Motley Fool
Exposures
Product Safety
Better Bull Market Buy: CRISPR Therapeutics vs. Pfizer Stock
December 21, 2023
These stocks are currently going in different directions, but both could go up in a new bull market.
Via
The Motley Fool
Is Vertex Pharmaceuticals Sitting on a Gold Mine?
December 21, 2023
Vertex shares have climbed about 40% this year.
Via
The Motley Fool
CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief
December 20, 2023
The fate of Crispr and CRSP stock will be determined by the success of other drugs in the company's pipeline rather than Casgevy.
Via
InvestorPlace
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
December 20, 2023
CRISPR Therapeutics stock has increased in the double digits this year.
Via
The Motley Fool
3 Genomics Stocks to Unlock the Future of Medicine
December 19, 2023
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.
Via
InvestorPlace
Exposures
Product Safety
Better Growth Stock: Archer Aviation or Prime Medicine?
December 19, 2023
Which of these innovation-themed growth stocks is the better buy?
Via
The Motley Fool
3 Healthcare Stocks That Could Help Make You a Millionaire
December 19, 2023
These stocks each have reached an important turning point that could signal growth ahead.
Via
The Motley Fool
2 Stocks Profiting From Unstoppable Trends That Could Make You Rich
December 18, 2023
It's important to choose companies involved in trends that have long-term potential.
Via
The Motley Fool
2 Stocks That Could Turn $1,000 Into $3,500 in 10 Years
December 17, 2023
These businesses are exciting and can also lead to outsized long-term returns.
Via
The Motley Fool
CRISPR Therapeutics Just Made History. So Why Did Its Stock Fall?
December 16, 2023
The benefits from its first drug launch will trickle in slowly, at least at first.
Via
The Motley Fool
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
December 16, 2023
These stocks could bring investors more than just a lump of coal for Christmas.
Via
The Motley Fool
Exposures
Coal
Here's the 1 Key Reason You Might Want to Buy CRISPR Therapeutics Stock on the Dip
December 16, 2023
This biotech could have more winners on the way.
Via
The Motley Fool
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
December 15, 2023
These pharma stock leaders offer revolutionary treatments that could change the world of medicine (and investor's portfolios) for the better.
Via
InvestorPlace
3 Small-Cap Stocks That Could Skyrocket 1000% by 2030
December 14, 2023
With the iShares Russell 2000 ETF (NYSE:IWM) on the move, investors should consider these small-cap stocks to buy.
Via
InvestorPlace
Topics
ETFs
Cathie Wood Just Dumped $40 Million of Coinbase Global (COIN) Stock
December 14, 2023
Wood is moving away from fintech and Internet names like COIN stock. She's now favoring genomics and artificial intelligence companies.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
1 Biotech Stock That Could Be the Next Amgen
December 13, 2023
The emergence of genomic medicine as a viable modality could transform this midcap biotech into the next Amgen.
Via
The Motley Fool
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
December 13, 2023
Both of these biotech stocks have been market-beaters over the prior 10 years. One stock, however, is a better buy right now.
Via
The Motley Fool
3 Gene-Editing Stocks With the Potential to Mint Millionaires
December 13, 2023
Gene editing stocks are very likely to see a spike in demand over the coming weeks in the wake of FDA approval of CRISPR.
Via
InvestorPlace
Exposures
Product Safety
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
31
32
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.